Medivie Therapeutic (Israel) Volatility
| MDVI Stock | ILA 35.50 2.00 5.97% |
Medivie Therapeutic has Sharpe Ratio of -0.23, which conveys that the firm had a -0.23% return per unit of risk over the last 3 months. Medivie Therapeutic exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Medivie Therapeutic's Mean Deviation of 3.72, risk adjusted performance of (0.11), and Standard Deviation of 4.56 to check out the risk estimate we provide. Key indicators related to Medivie Therapeutic's volatility include:
390 Days Market Risk | Chance Of Distress | 390 Days Economic Sensitivity |
Medivie Therapeutic Stock volatility depicts how high the prices fluctuate around the mean (or its average) price. In other words, it is a statistical measure of the distribution of Medivie daily returns, and it is calculated using variance and standard deviation. We also use Medivie's beta, its sensitivity to the market, as well as its odds of financial distress to provide a more practical estimation of Medivie Therapeutic volatility.
Medivie |
Since volatility provides investors with entry points to take advantage of stock prices, companies, such as Medivie Therapeutic can benefit from it. Downward market volatility can be a perfect environment for investors who play the long game as hey may decide to buy additional stocks of Medivie Therapeutic at lower prices to lower their average cost per share. Similarly, when the prices of Medivie Therapeutic's stock rise, investors can sell out and invest the proceeds in other equities with better opportunities.
Moving together with Medivie Stock
Moving against Medivie Stock
| 0.94 | PHOE | Phoenix Holdings | PairCorr |
| 0.92 | MMHD | Menora Miv Hld | PairCorr |
| 0.9 | INBR | Inbar Group Finance | PairCorr |
| 0.86 | MGDL | Migdal Insurance | PairCorr |
| 0.84 | HARL | Harel Insurance Inve | PairCorr |
| 0.84 | CLIS | Clal Insurance Enter | PairCorr |
| 0.8 | TSEM | Tower Semiconductor | PairCorr |
| 0.79 | ELAL | El Al Israel | PairCorr |
| 0.7 | BMDX | Biomedix Incubator | PairCorr |
Medivie Therapeutic Market Sensitivity And Downside Risk
Medivie Therapeutic's beta coefficient measures the volatility of Medivie stock compared to the systematic risk of the entire market represented by your selected benchmark. In mathematical terms, beta represents the slope of the line through a regression of data points where each of these points represents Medivie stock's returns against your selected market. In other words, Medivie Therapeutic's beta of -0.6 provides an investor with an approximation of how much risk Medivie Therapeutic stock can potentially add to one of your existing portfolios. Medivie Therapeutic exhibits very low volatility with skewness of -0.2 and kurtosis of -0.76. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Medivie Therapeutic's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Medivie Therapeutic's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.
3 Months Beta |Analyze Medivie Therapeutic Demand TrendCheck current 90 days Medivie Therapeutic correlation with market (Dow Jones Industrial)Medivie Beta |
Medivie standard deviation measures the daily dispersion of prices over your selected time horizon relative to its mean. A typical volatile entity has a high standard deviation, while the deviation of a stable instrument is usually low. As a downside, the standard deviation calculates all uncertainty as risk, even when it is in your favor, such as above-average returns.
Standard Deviation | 4.79 |
It is essential to understand the difference between upside risk (as represented by Medivie Therapeutic's standard deviation) and the downside risk, which can be measured by semi-deviation or downside deviation of Medivie Therapeutic's daily returns or price. Since the actual investment returns on holding a position in medivie stock tend to have a non-normal distribution, there will be different probabilities for losses than for gains. The likelihood of losses is reflected in the downside risk of an investment in Medivie Therapeutic.
Medivie Therapeutic Stock Volatility Analysis
Volatility refers to the frequency at which Medivie Therapeutic stock price increases or decreases within a specified period. These fluctuations usually indicate the level of risk that's associated with Medivie Therapeutic's price changes. Investors will then calculate the volatility of Medivie Therapeutic's stock to predict their future moves. A stock that has erratic price changes quickly hits new highs, and lows are considered highly volatile. A stock with relatively stable price changes has low volatility. A highly volatile stock is riskier, but the risk cuts both ways. Investing in highly volatile security can either be highly successful, or you may experience significant failure. There are two main types of Medivie Therapeutic's volatility:
Historical Volatility
This type of stock volatility measures Medivie Therapeutic's fluctuations based on previous trends. It's commonly used to predict Medivie Therapeutic's future behavior based on its past. However, it cannot conclusively determine the future direction of the stock.Implied Volatility
This type of volatility provides a positive outlook on future price fluctuations for Medivie Therapeutic's current market price. This means that the stock will return to its initially predicted market price. This type of volatility can be derived from derivative instruments written on Medivie Therapeutic's to be redeemed at a future date.Transformation |
The output start index for this execution was zero with a total number of output elements of sixty-one. Medivie Therapeutic Average Price is the average of the sum of open, high, low and close daily prices of a bar. It can be used to smooth an indicator that normally takes just the closing price as input.
Medivie Therapeutic Projected Return Density Against Market
Assuming the 90 days trading horizon Medivie Therapeutic has a beta of -0.6048 . This indicates as returns on the benchmark increase, returns on holding Medivie Therapeutic are expected to decrease at a much lower rate. During a bear market, however, Medivie Therapeutic is likely to outperform the market.Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Medivie Therapeutic or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Medivie Therapeutic's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Medivie stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Medivie Therapeutic has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Predicted Return Density |
| Returns |
What Drives a Medivie Therapeutic Price Volatility?
Several factors can influence a stock's market volatility:Industry
Specific events can influence volatility within a particular industry. For instance, a significant weather upheaval in a crucial oil-production site may cause oil prices to increase in the oil sector. The direct result will be the rise in the stock price of oil distribution companies. Similarly, any government regulation in a specific industry could negatively influence stock prices due to increased regulations on compliance that may impact the company's future earnings and growth.Political and Economic environment
When governments make significant decisions regarding trade agreements, policies, and legislation regarding specific industries, they will influence stock prices. Everything from speeches to elections may influence investors, who can directly influence the stock prices in any particular industry. The prevailing economic situation also plays a significant role in stock prices. When the economy is doing well, investors will have a positive reaction and hence, better stock prices and vice versa.The Company's Performance
Sometimes volatility will only affect an individual company. For example, a revolutionary product launch or strong earnings report may attract many investors to purchase the company. This positive attention will raise the company's stock price. In contrast, product recalls and data breaches may negatively influence a company's stock prices.Medivie Therapeutic Stock Risk Measures
Assuming the 90 days trading horizon the coefficient of variation of Medivie Therapeutic is -432.0. The daily returns are distributed with a variance of 22.93 and standard deviation of 4.79. The mean deviation of Medivie Therapeutic is currently at 4.09. For similar time horizon, the selected benchmark (Dow Jones Industrial) has volatility of 0.76
α | Alpha over Dow Jones | -0.66 | |
β | Beta against Dow Jones | -0.6 | |
σ | Overall volatility | 4.79 | |
Ir | Information ratio | -0.19 |
Medivie Therapeutic Stock Return Volatility
Medivie Therapeutic historical daily return volatility represents how much of Medivie Therapeutic stock's daily returns swing around its mean - it is a statistical measure of its dispersion of returns. The company accepts 4.7886% volatility on return distribution over the 90 days horizon. By contrast, Dow Jones Industrial accepts 0.7502% volatility on return distribution over the 90 days horizon. Performance |
| Timeline |
About Medivie Therapeutic Volatility
Volatility is a rate at which the price of Medivie Therapeutic or any other equity instrument increases or decreases for a given set of returns. It is measured by calculating the standard deviation of the annualized returns over a given period of time and shows the range to which the price of Medivie Therapeutic may increase or decrease. In other words, similar to Medivie's beta indicator, it measures the risk of Medivie Therapeutic and helps estimate the fluctuations that may happen in a short period of time. So if prices of Medivie Therapeutic fluctuate rapidly in a short time span, it is termed to have high volatility, and if it swings slowly in a more extended period, it is understood to have low volatility.
Please read more on our technical analysis page.Medivie Therapeutic Limited develops and markets dental devices. Medivie Therapeutic Limited was founded in 2012 and is based in Hemel Hempstead, the United Kingdom. MEDIVIE THERP is traded on Tel Aviv Stock Exchange in Israel.
Medivie Therapeutic's stock volatility refers to the amount of uncertainty or risk involved with the size of changes in its stock's price. It is a statistical measure of the dispersion of returns on Medivie Stock over a specified period of time, often expressed as the standard deviation of daily returns. In other words, it measures how much Medivie Therapeutic's price varies over time.
3 ways to utilize Medivie Therapeutic's volatility to invest better
Higher Medivie Therapeutic's stock volatility means that the price of its stock is changing rapidly and unpredictably, while lower stock volatility indicates that the price of Medivie Therapeutic stock is relatively stable. Investors and traders use stock volatility as an indicator of risk and potential reward, as stocks with higher volatility can offer the potential for more significant returns but also come with a greater risk of losses. Medivie Therapeutic stock volatility can provide helpful information for making investment decisions in the following ways:- Measuring Risk: Volatility can be used as a measure of risk, which can help you determine the potential fluctuations in the value of Medivie Therapeutic investment. A higher volatility means higher risk and potentially larger changes in value.
- Identifying Opportunities: High volatility in Medivie Therapeutic's stock can indicate that there is potential for significant price movements, either up or down, which could present investment opportunities.
- Diversification: Understanding how the volatility of Medivie Therapeutic's stock relates to your other investments can help you create a well-diversified portfolio of assets with varying levels of risk.
Medivie Therapeutic Investment Opportunity
Medivie Therapeutic has a volatility of 4.79 and is 6.39 times more volatile than Dow Jones Industrial. 42 percent of all equities and portfolios are less risky than Medivie Therapeutic. You can use Medivie Therapeutic to enhance the returns of your portfolios. The stock experiences a very speculative upward sentiment. Check odds of Medivie Therapeutic to be traded at 44.38 in 90 days.Good diversification
The correlation between Medivie Therapeutic and DJI is -0.1 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Medivie Therapeutic and DJI in the same portfolio, assuming nothing else is changed.
Medivie Therapeutic Additional Risk Indicators
The analysis of Medivie Therapeutic's secondary risk indicators is one of the essential steps in making a buy or sell decision. The process involves identifying the amount of risk involved in Medivie Therapeutic's investment and either accepting that risk or mitigating it. Along with some common measures of Medivie Therapeutic stock's risk such as standard deviation, beta, or value at risk, we also provide a set of secondary indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Risk Adjusted Performance | (0.11) | |||
| Market Risk Adjusted Performance | 1.23 | |||
| Mean Deviation | 3.72 | |||
| Coefficient Of Variation | (627.46) | |||
| Standard Deviation | 4.56 | |||
| Variance | 20.83 | |||
| Information Ratio | (0.19) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential stocks, we recommend comparing similar stocks with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Medivie Therapeutic Suggested Diversification Pairs
Pair trading is one of the very effective strategies used by professional day traders and hedge funds capitalizing on short-time and mid-term market inefficiencies. The approach is based on the fact that the ratio of prices of two correlating shares is long-term stable and oscillates around the average value. If the correlation ratio comes outside the common area, you can speculate with a high success rate that the ratio will return to the mean value and collect a profit.
| GM vs. Medivie Therapeutic | ||
| Ford vs. Medivie Therapeutic | ||
| Alphabet vs. Medivie Therapeutic | ||
| Microsoft vs. Medivie Therapeutic | ||
| Bank of America vs. Medivie Therapeutic | ||
| Visa vs. Medivie Therapeutic | ||
The effect of pair diversification on risk is to reduce it, but we should note this doesn't apply to all risk types. When we trade pairs against Medivie Therapeutic as a counterpart, there is always some inherent risk that will never be diversified away no matter what. This volatility limits the effect of tactical diversification using pair trading. Medivie Therapeutic's systematic risk is the inherent uncertainty of the entire market, and therefore cannot be mitigated even by pair-trading it against the equity that is not highly correlated to it. On the other hand, Medivie Therapeutic's unsystematic risk describes the types of risk that we can protect against, at least to some degree, by selecting a matching pair that is not perfectly correlated to Medivie Therapeutic.
Complementary Tools for Medivie Stock analysis
When running Medivie Therapeutic's price analysis, check to measure Medivie Therapeutic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medivie Therapeutic is operating at the current time. Most of Medivie Therapeutic's value examination focuses on studying past and present price action to predict the probability of Medivie Therapeutic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medivie Therapeutic's price. Additionally, you may evaluate how the addition of Medivie Therapeutic to your portfolios can decrease your overall portfolio volatility.
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |